312 related articles for article (PubMed ID: 30652346)
1. Clinical case report of patients with osteosarcoma and anticancer benefit of calycosin against human osteosarcoma cells.
Qiu R; Ma G; Li X; Shi Q; Li X; Zhou X; Tang Y; Xie Z; Liao S; Qin Y; Wang R; Ye Y; Luo J; Zhang J
J Cell Biochem; 2019 Jun; 120(6):10697-10706. PubMed ID: 30652346
[TBL] [Abstract][Full Text] [Related]
2. Antimetastatic effects of calycosin on osteosarcoma and the underlying mechanism.
Qiu R; Li X; Qin K; Chen X; Wang R; Dai Y; Deng L; Ye Y
Biofactors; 2019 Nov; 45(6):975-982. PubMed ID: 31322783
[TBL] [Abstract][Full Text] [Related]
3. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
Qiu R; Ma G; Zheng C; Qiu X; Li X; Li X; Mo J; Li Z; Liu Y; Mo L; Bi G; Ye Y
Exp Mol Pathol; 2014 Aug; 97(1):17-22. PubMed ID: 24797937
[TBL] [Abstract][Full Text] [Related]
4. Integrative findings indicate anti-tumor biotargets and molecular mechanisms of calycosin against osteosarcoma.
Tan J; Qin X; Liu B; Mo H; Wu Z; Yuan Z
Biomed Pharmacother; 2020 Jun; 126():110096. PubMed ID: 32179199
[TBL] [Abstract][Full Text] [Related]
5. Formononetin induces apoptosis of human osteosarcoma cell line U2OS by regulating the expression of Bcl-2, Bax and MiR-375 in vitro and in vivo.
Hu W; Xiao Z
Cell Physiol Biochem; 2015; 37(3):933-9. PubMed ID: 26381132
[TBL] [Abstract][Full Text] [Related]
6. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway.
Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD
Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818
[TBL] [Abstract][Full Text] [Related]
7. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
8. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Sun H; Yin M; Qian W; Yin H
Med Sci Monit; 2018 Sep; 24():6178-6186. PubMed ID: 30182951
[TBL] [Abstract][Full Text] [Related]
9. Tetramethylpyrazine inhibits osteosarcoma cell proliferation via downregulation of NF-κB in vitro and in vivo.
Wang Y; Fu Q; Zhao W
Mol Med Rep; 2013 Oct; 8(4):984-8. PubMed ID: 23912183
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of microRNA-340 promotes osteosarcoma cell apoptosis while suppressing proliferation, migration, and invasion by inactivating the CTNNB1-mediated Notch signaling pathway.
Pan BL; Wu L; Pan L; Yang YX; Li HH; Dai YJ; He ZQ; Tan L; Huang YG; Tong ZW; Liao JL
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29769415
[TBL] [Abstract][Full Text] [Related]
11. miR-1301/TRIAP1 Axis Participates in Epirubicin-Mediated Anti-Proliferation and Pro-Apoptosis in Osteosarcoma.
Yu L; Meng M; Bao Y; Zhang C; Gao B; Sa R; Luo W
Yonsei Med J; 2019 Sep; 60(9):832-841. PubMed ID: 31433581
[TBL] [Abstract][Full Text] [Related]
12. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q
Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772
[TBL] [Abstract][Full Text] [Related]
13. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
14. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 9 facilitates osteocarcinoma cell apoptosis and inhibits in vivo tumor growth.
Zhang J; Liang JH; Huang JG
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706722
[TBL] [Abstract][Full Text] [Related]
16. MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway.
Lu S; Liao QS; Tang L
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7633-7639. PubMed ID: 30536304
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo studies of antiosteosarcoma activities of formononetin.
Hu W; Wu X; Tang J; Xiao N; Zhao G; Zhang L; Ou L
J Cell Physiol; 2019 Aug; 234(10):17305-17313. PubMed ID: 30790283
[TBL] [Abstract][Full Text] [Related]
18. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
19. Histone methyltransferase NSD2 regulates apoptosis and chemosensitivity in osteosarcoma.
He C; Liu C; Wang L; Sun Y; Jiang Y; Hao Y
Cell Death Dis; 2019 Jan; 10(2):65. PubMed ID: 30683853
[TBL] [Abstract][Full Text] [Related]
20. X609, a novel manassantin A derivative, exhibits antitumor activity in MG-63 human osteosarcoma cells in vitro and in vivo.
Li J; Zhao K; Wang F; Cai J; Li Z; Zou L
Mol Med Rep; 2015 Aug; 12(2):3115-20. PubMed ID: 25954853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
